Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,025 public trials 2,027 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Vaccine Therapy in Treating Patients With Multiple Myeloma

NCT00019097

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +19 more
Locations
  • Arkansas Cancer Research Center Little Rock, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Medicine Branch Bethesda, Maryland, United States
View Trial Details
Completed

Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma

NCT04671251

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • James R. Berenson, MD., Inc. West Hollywood, California, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View Trial Details
Completed

Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb

NCT02012088

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Hospital Universitario de Alava Vitoria-Gasteiz, Alava, Spain
  • Hospital Clínico Universitario Lozano Blesa Zaragoza, Aragon, Spain
  • Hospital de Cabueñes Gijón, Asturas, Spain
  • Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain
View all 14 locations
View Trial Details

Related conditions